><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name></person-group>
<year>2009</year>. <article-title>Cell-mediated immune responses in tuberculosis.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>27</volume>: <fpage>393</fpage>&#x02013;<lpage>422</lpage><pub-id pub-id-type="pmid">19302046</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group>. <year>2001</year>. <article-title>Immunology of tuberculosis.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>19</volume>: <fpage>93</fpage>&#x02013;<lpage>129</lpage><pub-id pub-id-type="pmid">11244032</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>R. J.</given-names></name><name><surname>Jung</surname><given-names>Y. J.</given-names></name></person-group>. <year>2004</year>. <article-title>Immunity to tuberculosis.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>22</volume>: <fpage>599</fpage>&#x02013;<lpage>623</lpage><pub-id pub-id-type="pmid">15032590</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Magliozzo</surname><given-names>R. S.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group>. <year>1992</year>. <article-title>Killing of virulent <italic>Mycobacterium tuberculosis</italic> by reactive nitrogen intermediates produced by activated murine macrophages.</article-title>
<source>J. Exp. Med.</source>
<volume>175</volume>: <fpage>1111</fpage>&#x02013;<lpage>1122</lpage><pub-id pub-id-type="pmid">1552282</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J. D.</given-names></name><name><surname>North</surname><given-names>R. J.</given-names></name><name><surname>LaCourse</surname><given-names>R.</given-names></name><name><surname>Mudgett</surname><given-names>J. S.</given-names></name><name><surname>Shah</surname><given-names>S. K.</given-names></name><name><surname>Nathan</surname><given-names>C. F.</given-names></name></person-group>. <year>1997</year>. <article-title>Identification of nitric oxide synthase as a protective locus against tuberculosis.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>94</volume>: <fpage>5243</fpage>&#x02013;<lpage>5248</lpage><pub-id pub-id-type="pmid">9144222</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J. D.</given-names></name><name><surname>Taylor</surname><given-names>G. A.</given-names></name><name><surname>McKinney</surname><given-names>J. D.</given-names></name></person-group>. <year>2003</year>. <article-title>Immune control of tuberculosis by IFN-&#x003b3;-inducible LRG-47.</article-title>
<source>Science</source>
<volume>302</volume>: <fpage>654</fpage>&#x02013;<lpage>659</lpage><pub-id pub-id-type="pmid">14576437</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Magram</surname><given-names>J.</given-names></name><name><surname>Ferrante</surname><given-names>J.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>. <year>1997</year>. <article-title>Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with <italic>Mycobacterium tuberculosis.</italic></article-title>
<source>J. Exp. Med.</source>
<volume>186</volume>: <fpage>39</fpage>&#x02013;<lpage>45</lpage><pub-id pub-id-type="pmid">9206995</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Goldstein</surname><given-names>M. M.</given-names></name><name><surname>Triebold</surname><given-names>K. J.</given-names></name><name><surname>Sypek</surname><given-names>J.</given-names></name><name><surname>Wolf</surname><given-names>S.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group>. <year>1995</year>. <article-title>IL-12 increases resistance of BALB/c mice to <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>J. Immunol.</source>
<volume>155</volume>: <fpage>2515</fpage>&#x02013;<lpage>2524</lpage><pub-id pub-id-type="pmid">7650381</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bundschuh</surname><given-names>D. S.</given-names></name><name><surname>Barsig</surname><given-names>J.</given-names></name><name><surname>Hartung</surname><given-names>T.</given-names></name><name><surname>Randow</surname><given-names>F.</given-names></name><name><surname>D&#x000f6;cke</surname><given-names>W. D.</given-names></name><name><surname>Volk</surname><given-names>H. D.</given-names></name><name><surname>Wendel</surname><given-names>A.</given-names></name></person-group>. <year>1997</year>. <article-title>Granulocyte-macrophage colony-stimulating factor and IFN-&#x003b3; restore the systemic TNF-&#x003b1; response to endotoxin in lipopolysaccharide-desensitized mice.</article-title>
<source>J. Immunol.</source>
<volume>158</volume>: <fpage>2862</fpage>&#x02013;<lpage>2871</lpage><pub-id pub-id-type="pmid">9058823</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Dalton</surname><given-names>D. K.</given-names></name><name><surname>Stewart</surname><given-names>T. A.</given-names></name><name><surname>Griffin</surname><given-names>J. P.</given-names></name><name><surname>Russell</surname><given-names>D. G.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>. <year>1993</year>. <article-title>Disseminated tuberculosis in interferon &#x003b3; gene-disrupted mice.</article-title>
<source>J. Exp. Med.</source>
<volume>178</volume>: <fpage>2243</fpage>&#x02013;<lpage>2247</lpage><pub-id pub-id-type="pmid">8245795</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>M.</given-names></name></person-group>
<year>1991</year>. <article-title>Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis.</article-title>
<source>J. Leukoc. Biol.</source>
<volume>50</volume>: <fpage>495</fpage>&#x02013;<lpage>501</lpage><pub-id pub-id-type="pmid">1748843</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>M.</given-names></name></person-group>
<year>1991</year>. <article-title>Interferon-&#x003b3;-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates.</article-title>
<source>Cell. Immunol.</source>
<volume>132</volume>: <fpage>150</fpage>&#x02013;<lpage>157</lpage><pub-id pub-id-type="pmid">1905984</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000e9;ry</surname><given-names>R. E.</given-names></name><name><surname>Bissonnette</surname><given-names>E. Y.</given-names></name></person-group>. <year>1999</year>. <article-title>IFN-&#x003b3; potentiates the release of TNF-&#x003b1; and MIP-1&#x003b1; by alveolar macrophages during allergic reactions.</article-title>
<source>Am. J. Respir. Cell Mol. Biol.</source>
<volume>20</volume>: <fpage>407</fpage>&#x02013;<lpage>412</lpage><pub-id pub-id-type="pmid">10030838</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Triebold</surname><given-names>K. J.</given-names></name><name><surname>Dalton</surname><given-names>D. K.</given-names></name><name><surname>Stewart</surname><given-names>T. A.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group>. <year>1993</year>. <article-title>An essential role for interferon &#x003b3; in resistance to <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>J. Exp. Med.</source>
<volume>178</volume>: <fpage>2249</fpage>&#x02013;<lpage>2254</lpage><pub-id pub-id-type="pmid">7504064</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>L. R.</given-names></name><name><surname>Gigliotti Rothfuchs</surname><given-names>A.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>R.</given-names></name><name><surname>Roff&#x000ea;</surname><given-names>E.</given-names></name><name><surname>Cheever</surname><given-names>A. W.</given-names></name><name><surname>Bafica</surname><given-names>A.</given-names></name><name><surname>Salazar</surname><given-names>A. M.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group>. <year>2010</year>. <article-title>Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.</article-title>
<source>J. Clin. Invest.</source>
<volume>120</volume>: <fpage>1674</fpage>&#x02013;<lpage>1682</lpage><pub-id pub-id-type="pmid">20389020</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>M. P.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Bloch</surname><given-names>S. A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><name><surname>Wilkinson</surname><given-names>K. A.</given-names></name><name><surname>Banchereau</surname><given-names>R.</given-names></name><name><surname>Skinner</surname><given-names>J.</given-names></name><name><surname>Wilkinson</surname><given-names>R. J.</given-names></name><etal/></person-group>. <year>2010</year>. <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.</article-title>
<source>Nature</source>
<volume>466</volume>: <fpage>973</fpage>&#x02013;<lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J.</given-names></name><name><surname>Repsilber</surname><given-names>D.</given-names></name><name><surname>Parida</surname><given-names>S. K.</given-names></name><name><surname>Stanley</surname><given-names>K.</given-names></name><name><surname>Roberts</surname><given-names>T.</given-names></name><name><surname>Black</surname><given-names>G.</given-names></name><name><surname>Walzl</surname><given-names>G.</given-names></name><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name></person-group>. <year>2011</year>. <article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis.</article-title>
<source>Genes Immun.</source>
<volume>12</volume>: <fpage>15</fpage>&#x02013;<lpage>22</lpage><pub-id pub-id-type="pmid">20861863</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Bergtold</surname><given-names>A.</given-names></name><name><surname>Freeman</surname><given-names>S.</given-names></name><name><surname>Tovey</surname><given-names>M.</given-names></name><name><surname>Musser</surname><given-names>J. M.</given-names></name><name><surname>Barry</surname><given-names>C. E.</given-names><suffix>III.</suffix></name><name><surname>Freedman</surname><given-names>V. H.</given-names></name><name><surname>Kaplan</surname><given-names>G.</given-names></name></person-group>. <year>2001</year>. <article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-&#x003b1;/&#x003b2;.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>98</volume>: <fpage>5752</fpage>&#x02013;<lpage>5757</lpage><pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Freeman</surname><given-names>S.</given-names></name><name><surname>Barczak</surname><given-names>A. K.</given-names></name><name><surname>Tovey</surname><given-names>M.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>Barry</surname><given-names>C.</given-names></name><name><surname>Kaplan</surname><given-names>G.</given-names></name></person-group>. <year>2005</year>. <article-title>Hypervirulent <italic>M. tuberculosis</italic> W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.</article-title>
<source>J. Interferon Cytokine Res.</source>
<volume>25</volume>: <fpage>694</fpage>&#x02013;<lpage>701</lpage><pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Andrade</surname><given-names>B. B.</given-names></name><name><surname>Barber</surname><given-names>D. L.</given-names></name><name><surname>Hieny</surname><given-names>S.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name><name><surname>Caspar</surname><given-names>P.</given-names></name><name><surname>Oland</surname><given-names>S.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group>. <year>2011</year>. <article-title>Innate and adaptive interferons suppress IL-1&#x003b1; and IL-1&#x003b2; production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>Immunity</source>
<volume>35</volume>: <fpage>1023</fpage>&#x02013;<lpage>1034</lpage><pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A.</given-names></name><name><surname>Cardone</surname><given-names>M.</given-names></name><name><surname>Thompson</surname><given-names>R.</given-names></name><name><surname>Shenderov</surname><given-names>K.</given-names></name><name><surname>Kirschman</surname><given-names>K. D.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Myers</surname><given-names>T. G.</given-names></name><name><surname>Rabin</surname><given-names>R. L.</given-names></name><name><surname>Trinchieri</surname><given-names>G.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Feng</surname><given-names>C. G.</given-names></name></person-group>. <year>2011</year>. <article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1&#x003b2; production in human macrophages.</article-title>
<source>J. Immunol.</source>
<volume>187</volume>: <fpage>2540</fpage>&#x02013;<lpage>2547</lpage><pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordway</surname><given-names>D.</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M.</given-names></name><name><surname>Harton</surname><given-names>M.</given-names></name><name><surname>Palanisamy</surname><given-names>G.</given-names></name><name><surname>Troudt</surname><given-names>J.</given-names></name><name><surname>Shanley</surname><given-names>C.</given-names></name><name><surname>Basaraba</surname><given-names>R. J.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>. <year>2007</year>. <article-title>The hypervirulent <italic>Mycobacterium tuberculosis</italic> strain HN878 induces a potent T<sub>H</sub>1 response followed by rapid down-regulation.</article-title>
<source>J. Immunol.</source>
<volume>179</volume>: <fpage>522</fpage>&#x02013;<lpage>531</lpage><pub-id pub-id-type="pmid">17579073</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>T. H.</given-names></name><name><surname>Dass</surname><given-names>R. H.</given-names></name><name><surname>Yang</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>M. M.</given-names></name><name><surname>Wong</surname><given-names>H. E.</given-names></name><name><surname>Sahiratmadja</surname><given-names>E.</given-names></name><name><surname>Khor</surname><given-names>C. C.</given-names></name><name><surname>Alisjahbana</surname><given-names>B.</given-names></name><name><surname>van Crevel</surname><given-names>R.</given-names></name><name><surname>Marzuki</surname><given-names>S.</given-names></name><etal/></person-group>. <year>2012</year>. <article-title>Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis.</article-title>
<source>PLoS ONE</source>
<volume>7</volume>: <fpage>e45839</fpage><pub-id pub-id-type="pmid">23029268</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>S. A.</given-names></name><name><surname>Johndrow</surname><given-names>J. E.</given-names></name><name><surname>Manzanillo</surname><given-names>P.</given-names></name><name><surname>Cox</surname><given-names>J. S.</given-names></name></person-group>. <year>2007</year>. <article-title>The type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis.</article-title>
<source>J. Immunol.</source>
<volume>178</volume>: <fpage>3143</fpage>&#x02013;<lpage>3152</lpage><pub-id pub-id-type="pmid">17312162</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Dong</surname><given-names>D.</given-names></name><name><surname>Fang</surname><given-names>H.</given-names></name><name><surname>Levillain</surname><given-names>F.</given-names></name><name><surname>Jin</surname><given-names>W.</given-names></name><name><surname>Mei</surname><given-names>J.</given-names></name><name><surname>Gicquel</surname><given-names>B.</given-names></name><name><surname>Du</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Gao</surname><given-names>Q.</given-names></name><etal/></person-group>. <year>2012</year>. <article-title>An interferon-related signature in the transcriptional core response of human macrophages to <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>PLoS ONE</source>
<volume>7</volume>: <fpage>e38367</fpage><pub-id pub-id-type="pmid">22675550</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Pearl</surname><given-names>J. E.</given-names></name><name><surname>Brooks</surname><given-names>J. V.</given-names></name><name><surname>Ehlers</surname><given-names>S.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name></person-group>. <year>2000</year>. <article-title>Expression of the nitric oxide synthase 2 gene is not essential for early control of <italic>Mycobacterium tuberculosis</italic> in the murine lung.</article-title>
<source>Infect. Immun.</source>
<volume>68</volume>: <fpage>6879</fpage>&#x02013;<lpage>6882</lpage><pub-id pub-id-type="pmid">11083808</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L.</given-names></name><name><surname>Wolf</surname><given-names>A. J.</given-names></name><name><surname>Ernst</surname><given-names>J. D.</given-names></name></person-group>. <year>2012</year>. <article-title>Dynamic roles of type I and type II IFNs in early infection with <italic>Mycobacterium tuberculosis.</italic></article-title>
<source>J. Immunol.</source>
<volume>188</volume>: <fpage>6205</fpage>&#x02013;<lpage>6215</lpage><pub-id pub-id-type="pmid">22566567</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Ewbank</surname><given-names>J.</given-names></name><name><surname>Rajsbaum</surname><given-names>R.</given-names></name><name><surname>Stavropoulos</surname><given-names>E.</given-names></name><name><surname>Martirosyan</surname><given-names>A.</given-names></name><name><surname>Redford</surname><given-names>P. S.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>Saraiva</surname><given-names>M.</given-names></name><name><surname>Tsichlis</surname><given-names>P.</given-names></name><etal/></person-group>. <year>2013</year>. <article-title>TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.</article-title>
<source>J. Immunol.</source>
<volume>191</volume>: <fpage>1732</fpage>&#x02013;<lpage>1743</lpage><pub-id pub-id-type="pmid">23842752</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cliff</surname><given-names>J. M.</given-names></name><name><surname>Lee</surname><given-names>J. S.</given-names></name><name><surname>Constantinou</surname><given-names>N.</given-names></name><name><surname>Cho</surname><given-names>J. E.</given-names></name><name><surname>Clark</surname><given-names>T. G.</given-names></name><name><surname>Ronacher</surname><given-names>K.</given-names></name><name><surname>King</surname><given-names>E. C.</given-names></name><name><surname>Lukey</surname><given-names>P. T.</given-names></name><name><surname>Duncan</surname><given-names>K.</given-names></name><name><surname>Van Helden</surname><given-names>P. D.</given-names></name><etal/></person-group>. <year>2013</year>. <article-title>Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response.</article-title>
<source>J. Infect. Dis.</source>
<volume>207</volume>: <fpage>18</fpage>&#x02013;<lpage>29</lpage><pub-id pub-id-type="pmid">22872737</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>E. Y.</given-names></name><name><surname>Guo</surname><given-names>B.</given-names></name><name><surname>Doyle</surname><given-names>S. E.</given-names></name><name><surname>Cheng</surname><given-names>G.</given-names></name></person-group>. <year>2007</year>. <article-title>Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production.</article-title>
<source>J. Immunol.</source>
<volume>178</volume>: <fpage>6705</fpage>&#x02013;<lpage>6709</lpage><pub-id pub-id-type="pmid">17513714</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G.</given-names></name><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Staehli</surname><given-names>F.</given-names></name><name><surname>Tardivel</surname><given-names>A.</given-names></name><name><surname>Mattmann</surname><given-names>C.</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>I.</given-names></name><name><surname>Farlik</surname><given-names>M.</given-names></name><name><surname>Decker</surname><given-names>T.</given-names></name><name><surname>Du Pasquier</surname><given-names>R. A.</given-names></name><name><surname>Romero</surname><given-names>P.</given-names></name><name><surname>Tschopp</surname><given-names>J.</given-names></name></person-group>. <year>2011</year>. <article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation.</article-title>
<source>Immunity</source>
<volume>34</volume>: <fpage>213</fpage>&#x02013;<lpage>223</lpage><pub-id pub-id-type="pmid">21349431</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>S. S.</given-names></name><name><surname>Ghaffari</surname><given-names>A. A.</given-names></name><name><surname>Cheng</surname><given-names>G.</given-names></name></person-group>. <year>2010</year>. <article-title>Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages.</article-title>
<source>J. Immunol.</source>
<volume>185</volume>: <fpage>6599</fpage>&#x02013;<lpage>6607</lpage><pub-id pub-id-type="pmid">21041726</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbuch</surname><given-names>V.</given-names></name><name><surname>Brockstedt</surname><given-names>D. G.</given-names></name><name><surname>Meyer-Morse</surname><given-names>N.</given-names></name><name><surname>O&#x02019;Riordan</surname><given-names>M.</given-names></name><name><surname>Portnoy</surname><given-names>D. A.</given-names></name></person-group>. <year>2004</year>. <article-title>Mice lacking the type I interferon receptor are resistant to <italic>Listeria monocytogenes.</italic></article-title>
<source>J. Exp. Med.</source>
<volume>200</volume>: <fpage>527</fpage>&#x02013;<lpage>533</lpage><pub-id pub-id-type="pmid">15302899</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>J. A.</given-names></name><name><surname>Calderon</surname><given-names>B.</given-names></name><name><surname>Unanue</surname><given-names>E. R.</given-names></name></person-group>. <year>2004</year>. <article-title>Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to <italic>Listeria</italic> infection.</article-title>
<source>J. Exp. Med.</source>
<volume>200</volume>: <fpage>535</fpage>&#x02013;<lpage>540</lpage><pub-id pub-id-type="pmid">15302900</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname><given-names>R. M.</given-names></name><name><surname>Saha</surname><given-names>S. K.</given-names></name><name><surname>Vaidya</surname><given-names>S. A.</given-names></name><name><surname>Bruhn</surname><given-names>K. W.</given-names></name><name><surname>Miranda</surname><given-names>G. A.</given-names></name><name><surname>Zarnegar</surname><given-names>B.</given-names></name><name><surname>Perry</surname><given-names>A. K.</given-names></name><name><surname>Nguyen</surname><given-names>B. O.</given-names></name><name><surname>Lane</surname><given-names>T. F.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name><etal/></person-group>. <year>2004</year>. <article-title>Type I interferon production enhances susceptibility to <italic>Listeria monocytogenes</italic> infection.</article-title>
<source>J. Exp. Med.</source>
<volume>200</volume>: <fpage>437</fpage>&#x02013;<lpage>445</lpage><pub-id pub-id-type="pmid">15302901</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>S.</given-names></name><name><surname>Kastner</surname><given-names>R.</given-names></name><name><surname>Kernbauer</surname><given-names>E.</given-names></name><name><surname>Pilz</surname><given-names>A.</given-names></name><name><surname>Westermayer</surname><given-names>S.</given-names></name><name><surname>Reutterer</surname><given-names>B.</given-names></name><name><surname>Soulat</surname><given-names>D.</given-names></name><name><surname>Stengl</surname><given-names>G.</given-names></name><name><surname>Vogl</surname><given-names>C.</given-names></name><name><surname>Frenz</surname><given-names>T.</given-names></name><etal/></person-group>. <year>2009</year>. <article-title>Characterization of the interferon-producing cell in mice infected with <italic>Listeria monocytogenes.</italic></article-title>
<source>PLoS Pathog.</source>
<volume>5</volume>: <fpage>e1000355</fpage><pub-id pub-id-type="pmid">19325882</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beamer</surname><given-names>G. L.</given-names></name><name><surname>Flaherty</surname><given-names>D. K.</given-names></name><name><surname>Assogba</surname><given-names>B. D.</given-names></name><name><surname>Stromberg</surname><given-names>P.</given-names></name><name><surname>Gonzalez-Juarrero</surname><given-names>M.</given-names></name><name><surname>de Waal Malefyt</surname><given-names>R.</given-names></name><name><surname>Vesosky</surname><given-names>B.</given-names></name><name><surname>Turner</surname><given-names>J.</given-names></name></person-group>. <year>2008</year>. <article-title>Interleukin-10 promotes <italic>Mycobacterium tuberculosis</italic> disease progression in CBA/J mice.</article-title>
<source>J. Immunol.</source>
<volume>181</volume>: <fpage>5545</fpage>&#x02013;<lpage>5550</lpage><pub-id pub-id-type="pmid">18832712</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demangel</surname><given-names>C.</given-names></name><name><surname>Bertolino</surname><given-names>P.</given-names></name><name><surname>Britton</surname><given-names>W. J.</given-names></name></person-group>. <year>2002</year>. <article-title>Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production.</article-title>
<source>Eur. J. Immunol.</source>
<volume>32</volume>: <fpage>994</fpage>&#x02013;<lpage>1002</lpage><pub-id pub-id-type="pmid">11920565</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>P. S.</given-names></name><name><surname>Boonstra</surname><given-names>A.</given-names></name><name><surname>Read</surname><given-names>S.</given-names></name><name><surname>Pitt</surname><given-names>J.</given-names></name><name><surname>Graham</surname><given-names>C.</given-names></name><name><surname>Stavropoulos</surname><given-names>E.</given-names></name><name><surname>Bancroft</surname><given-names>G. J.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group>. <year>2010</year>. <article-title>Enhanced protection to <italic>Mycobacterium tuberculosis</italic> infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung.</article-title>
<source>Eur. J. Immunol.</source>
<volume>40</volume>: <fpage>2200</fpage>&#x02013;<lpage>2210</lpage><pub-id pub-id-type="pmid">20518032</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>P. S.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group>. <year>2011</year>. <article-title>The role of IL-10 in immune regulation during <italic>M. tuberculosis</italic> infection.</article-title>
<source>Mucosal Immunol.</source>
<volume>4</volume>: <fpage>261</fpage>&#x02013;<lpage>270</lpage><pub-id pub-id-type="pmid">21451501</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>J.</given-names></name><name><surname>Gonzalez-Juarrero</surname><given-names>M.</given-names></name><name><surname>Ellis</surname><given-names>D. L.</given-names></name><name><surname>Basaraba</surname><given-names>R. J.</given-names></name><name><surname>Kipnis</surname><given-names>A.</given-names></name><name><surname>Orme</surname><given-names>I. M.</given-names></name><name><surname>Cooper</surname><given-names>A. M.</given-names></name></person-group>. <year>2002</year>. <article-title>In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice.</article-title>
<source>J. Immunol.</source>
<volume>169</volume>: <fpage>6343</fpage>&#x02013;<lpage>6351</lpage><pub-id pub-id-type="pmid">12444141</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>R. M.</given-names></name><name><surname>Graeber</surname><given-names>T. G.</given-names></name><name><surname>Krutzik</surname><given-names>S. R.</given-names></name><name><surname>Montoya</surname><given-names>D.</given-names></name><name><surname>Schenk</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>D. J.</given-names></name><name><surname>Komisopoulou</surname><given-names>E.</given-names></name><name><surname>Kelly-Scumpia</surname><given-names>K.</given-names></name><name><surname>Chun</surname><given-names>R.</given-names></name><name><surname>Iyer</surname><given-names>S. S.</given-names></name><etal/></person-group>. <year>2013</year>. <article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.</article-title>
<source>Science</source>
<volume>339</volume>: <fpage>1448</fpage>&#x02013;<lpage>1453</lpage><pub-id pub-id-type="pmid">23449998</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M.</given-names></name><name><surname>Humann</surname><given-names>J.</given-names></name><name><surname>Penheiter</surname><given-names>K.</given-names></name><name><surname>Andreasen</surname><given-names>K.</given-names></name><name><surname>Lenz</surname><given-names>L. L.</given-names></name></person-group>. <year>2010</year>. <article-title>Induction of IFN-&#x003b1;&#x003b2; enables <italic>Listeria monocytogenes</italic> to suppress macrophage activation by IFN-&#x003b3;.</article-title>
<source>J. Exp. Med.</source>
<volume>207</volume>: <fpage>327</fpage>&#x02013;<lpage>337</lpage><pub-id pub-id-type="pmid">20123961</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>F.</given-names></name><name><surname>Cook</surname><given-names>D.</given-names></name><name><surname>Papoutsopoulou</surname><given-names>S.</given-names></name><name><surname>Rajsbaum</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>H. T.</given-names></name><name><surname>Grant</surname><given-names>S.</given-names></name><name><surname>Ricciardi-Castagnoli</surname><given-names>P.</given-names></name><name><surname>Tsichlis</surname><given-names>P. N.</given-names></name><name><surname>Ley</surname><given-names>S. C.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group>. <year>2009</year>. <article-title>TPL-2 negatively regulates interferon-&#x003b2; production in macrophages and myeloid dendritic cells.</article-title>
<source>J. Exp. Med.</source>
<volume>206</volume>: <fpage>1863</fpage>&#x02013;<lpage>1871</lpage><pub-id pub-id-type="pmid">19667062</pub-id></mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awasthi</surname><given-names>A.</given-names></name><name><surname>Carrier</surname><given-names>Y.</given-names></name><name><surname>Peron</surname><given-names>J. P.</given-names></name><name><surname>Bettelli</surname><given-names>E.</given-names></name><name><surname>Kamanaka</surname><given-names>M.</given-names></name><name><surname>Flavell</surname><given-names>R. A.</given-names></name><name><surname>Kuchroo</surname><given-names>V. K.</given-names></name><name><surname>Oukka</surname><given-names>M.</given-names></name><name><surname>Weiner</surname><given-names>H. L.</given-names></name></person-group>. <year>2007</year>. <article-title>A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.</article-title>
<source>Nat. Immunol.</source>
<volume>8</volume>: <fpage>1380</fpage>&#x02013;<lpage>1389</lpage><pub-id pub-id-type="pmid">17994022</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>D. C.</given-names></name><name><surname>Zhang</surname><given-names>G. X.</given-names></name><name><surname>El-Behi</surname><given-names>M.</given-names></name><name><surname>Fonseca-Kelly</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Saris</surname><given-names>C. J.</given-names></name><name><surname>Gran</surname><given-names>B.</given-names></name><name><surname>Ciric</surname><given-names>B.</given-names></name><name><surname>Rostami</surname><given-names>A.</given-names></name></person-group>. <year>2007</year>. <article-title>Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.</article-title>
<source>Nat. Immunol.</source>
<volume>8</volume>: <fpage>1372</fpage>&#x02013;<lpage>1379</lpage><pub-id pub-id-type="pmid">17994023</pub-id></mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stumhofer</surname><given-names>J. S.</given-names></name><name><surname>Silver</surname><given-names>J. S.</given-names></name><name><surname>Laurence</surname><given-names>A.</given-names></name><name><surname>Porrett</surname><given-names>P. M.</given-names></name><name><surname>Harris</surname><given-names>T. H.</given-names></name><name><surname>Turka</surname><given-names>L. A.</given-names></name><name><surname>Ernst</surname><given-names>M.</given-names></name><name><surname>Saris</surname><given-names>C. J.</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>J. J.</given-names></name><name><surname>Hunter</surname><given-names>C. A.</given-names></name></person-group>. <year>2007</year>. <article-title>Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.</article-title>
<source>Nat. Immunol.</source>
<volume>8</volume>: <fpage>1363</fpage>&#x02013;<lpage>1371</lpage><pub-id pub-id-type="pmid">17994025</pub-id></mixed-citation></ref><ref id="r48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalliolias</surname><given-names>G. D.</given-names></name><name><surname>Ivashkiv</surname><given-names>L. B.</given-names></name></person-group>. <year>2008</year>. <article-title>IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38.</article-title>
<source>J. Immunol.</source>
<volume>180</volume>: <fpage>6325</fpage>&#x02013;<lpage>6333</lpage><pub-id pub-id-type="pmid">18424756</pub-id></mixed-citation></ref><ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeitvogel</surname><given-names>J.</given-names></name><name><surname>Werfel</surname><given-names>T.</given-names></name><name><surname>Wittmann</surname><given-names>M.</given-names></name></person-group>. <year>2012</year>. <article-title>IL-27 acts as a priming signal for IL-23 but not IL-12 production on human antigen-presenting cells.</article-title>
<source>Exp. Dermatol.</source>
<volume>21</volume>: <fpage>426</fpage>&#x02013;<lpage>430</lpage><pub-id pub-id-type="pmid">22621182</pub-id></mixed-citation></ref><ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>H.</given-names></name><name><surname>Hamano</surname><given-names>S.</given-names></name><name><surname>Senaldi</surname><given-names>G.</given-names></name><name><surname>Covey</surname><given-names>T.</given-names></name><name><surname>Faggioni</surname><given-names>R.</given-names></name><name><surname>Mu</surname><given-names>S.</given-names></name><name><surname>Xia</surname><given-names>M.</given-names></name><name><surname>Wakeham</surname><given-names>A. C.</given-names></name><name><surname>Nishina</surname><given-names>H.</given-names></name><name><surname>Potter</surname><given-names>J.</given-names></name><etal/></person-group>. <year>2001</year>. <article-title>WSX-1 is required for the initiation of Th1 responses and resistance to <italic>L. major</italic> infection.</article-title>
<source>Immunity</source>
<volume>15</volume>: <fpage>569</fpage>&#x02013;<lpage>578</lpage><pub-id pub-id-type="pmid">11672539</pub-id></mixed-citation></ref><ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdi</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Matzinger</surname><given-names>P.</given-names></name></person-group>. <year>2006</year>. <article-title>T-cell control of IL-12p75 production.</article-title>
<source>Scand. J. Immunol.</source>
<volume>64</volume>: <fpage>83</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="pmid">16867152</pub-id></mixed-citation></ref><ref id="r52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>M. P.</given-names></name><name><surname>Freeman</surname><given-names>S. L.</given-names></name><name><surname>Donnelly</surname><given-names>R. P.</given-names></name></person-group>. <year>1995</year>. <article-title>IFN-&#x003b3; priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability.</article-title>
<source>Cytokine</source>
<volume>7</volume>: <fpage>427</fpage>&#x02013;<lpage>435</lpage><pub-id pub-id-type="pmid">7578980</pub-id></mixed-citation></ref><ref id="r53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>M. P.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Norcross</surname><given-names>M. A.</given-names></name></person-group>. <year>1995</year>. <article-title>Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-&#x003b3; of lipopolysaccharide-inducible p35 and p40 genes.</article-title>
<source>Blood</source>
<volume>86</volume>: <fpage>646</fpage>&#x02013;<lpage>650</lpage><pub-id pub-id-type="pmid">7605994</pub-id></mixed-citation></ref><ref id="r54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>S. J.</given-names></name><name><surname>Delgado</surname><given-names>C.</given-names></name><name><surname>Eshleman</surname><given-names>E. M.</given-names></name><name><surname>Hill</surname><given-names>K. K.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>B. P.</given-names></name><name><surname>Lenz</surname><given-names>L. L.</given-names></name></person-group>. <year>2013</year>. <article-title>Type I IFNs downregulate myeloid cell IFN-&#x003b3; receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences <italic>ifngr1</italic> transcription.</article-title>
<source>J. Immunol.</source>
<volume>191</volume>: <fpage>3384</fpage>&#x02013;<lpage>3392</lpage><pub-id pub-id-type="pmid">23935197</pub-id></mixed-citation></ref><ref id="r55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>K. W.</given-names></name><name><surname>de Waal Malefyt</surname><given-names>R.</given-names></name><name><surname>Coffman</surname><given-names>R. L.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group>. <year>2001</year>. <article-title>Interleukin-10 and the interleukin-10 receptor.</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>19</volume>: <fpage>683</fpage>&#x02013;<lpage>765</lpage><pub-id pub-id-type="pmid">11244051</pub-id></mixed-citation></ref><ref id="r56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G.</given-names></name></person-group>
<year>2003</year>. <article-title>Interleukin-12 and the regulation of innate resistance and adaptive immunity.</article-title>
<source>Nat. Rev. Immunol.</source>
<volume>3</volume>: <fpage>133</fpage>&#x02013;<lpage>146</lpage><pub-id pub-id-type="pmid">12563297</pub-id></mixed-citation></ref><ref id="r57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>B. B.</given-names></name><name><surname>Rathinam</surname><given-names>V. A.</given-names></name><name><surname>Martens</surname><given-names>G. W.</given-names></name><name><surname>Martinot</surname><given-names>A. J.</given-names></name><name><surname>Kornfeld</surname><given-names>H.</given-names></name><name><surname>Fitzgerald</surname><given-names>K. A.</given-names></name><name><surname>Sassetti</surname><given-names>C. M.</given-names></name></person-group>. <year>2013</year>. <article-title>Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1&#x003b2;.</article-title>
<source>Nat. Immunol.</source>
<volume>14</volume>: <fpage>52</fpage>&#x02013;<lpage>60</lpage><pub-id pub-id-type="pmid">23160153</pub-id></mixed-citation></ref><ref id="r58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flesch</surname><given-names>I. E.</given-names></name><name><surname>Kaufmann</surname><given-names>S. H.</given-names></name></person-group>. <year>1991</year>. <article-title>Mechanisms involved in mycobacterial growth inhibition by &#x003b3; interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates.</article-title>
<source>Infect. Immun.</source>
<volume>59</volume>: <fpage>3213</fpage>&#x02013;<lpage>3218</lpage><pub-id pub-id-type="pmid">1908829</pub-id></mixed-citation></ref><ref id="r59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>Y. J.</given-names></name><name><surname>LaCourse</surname><given-names>R.</given-names></name><name><surname>Ryan</surname><given-names>L.</given-names></name><name><surname>North</surname><given-names>R. J.</given-names></name></person-group>. <year>2002</year>. <article-title>Virulent but not avirulent <italic>Mycobacterium tuberculosis</italic> can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice.</article-title>
<source>J. Exp. Med.</source>
<volume>196</volume>: <fpage>991</fpage>&#x02013;<lpage>998</lpage><pub-id pub-id-type="pmid">12370260</pub-id></mixed-citation></ref><ref id="r60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>A. H.</given-names></name><name><surname>Nathan</surname><given-names>C. F.</given-names></name><name><surname>Stuehr</surname><given-names>D. J.</given-names></name></person-group>. <year>1988</year>. <article-title>Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.</article-title>
<source>J. Immunol.</source>
<volume>141</volume>: <fpage>2407</fpage>&#x02013;<lpage>2412</lpage><pub-id pub-id-type="pmid">3139757</pub-id></mixed-citation></ref><ref id="r61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Goldstein</surname><given-names>M. M.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Triebold</surname><given-names>K. J.</given-names></name><name><surname>Pfeffer</surname><given-names>K.</given-names></name><name><surname>Lowenstein</surname><given-names>C. J.</given-names></name><name><surname>Schreiber</surname><given-names>R.</given-names></name><name><surname>Mak</surname><given-names>T. W.</given-names></name><name><surname>Bloom</surname><given-names>B. R.</given-names></name></person-group>. <year>1995</year>. <article-title>Tumor necrosis factor-&#x003b1; is required in the protective immune response against <italic>Mycobacterium tuberculosis</italic> in mice.</article-title>
<source>Immunity</source>
<volume>2</volume>: <fpage>561</fpage>&#x02013;<lpage>572</lpage><pub-id pub-id-type="pmid">7540941</pub-id></mixed-citation></ref><ref id="r62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fremond</surname><given-names>C. M.</given-names></name><name><surname>Togbe</surname><given-names>D.</given-names></name><name><surname>Doz</surname><given-names>E.</given-names></name><name><surname>Rose</surname><given-names>S.</given-names></name><name><surname>Vasseur</surname><given-names>V.</given-names></name><name><surname>Maillet</surname><given-names>I.</given-names></name><name><surname>Jacobs</surname><given-names>M.</given-names></name><name><surname>Ryffel</surname><given-names>B.</given-names></name><name><surname>Quesniaux</surname><given-names>V. F.</given-names></name></person-group>. <year>2007</year>. <article-title>IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to <italic>Mycobacterium tuberculosis</italic> infection.</article-title>
<source>J. Immunol.</source>
<volume>179</volume>: <fpage>1178</fpage>&#x02013;<lpage>1189</lpage><pub-id pub-id-type="pmid">17617611</pub-id></mixed-citation></ref><ref id="r63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Barber</surname><given-names>D. L.</given-names></name><name><surname>Shenderov</surname><given-names>K.</given-names></name><name><surname>White</surname><given-names>S. D.</given-names></name><name><surname>Wilson</surname><given-names>M. S.</given-names></name><name><surname>Cheever</surname><given-names>A.</given-names></name><name><surname>Kugler</surname><given-names>D.</given-names></name><name><surname>Hieny</surname><given-names>S.</given-names></name><name><surname>Caspar</surname><given-names>P.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>G.</given-names></name><etal/></person-group>. <year>2010</year>. <article-title>Caspase-1 independent IL-1&#x003b2; production is critical for host resistance to <italic>Mycobacterium tuberculosis</italic> and does not require TLR signaling in vivo.</article-title>
<source>J. Immunol.</source>
<volume>184</volume>: <fpage>3326</fpage>&#x02013;<lpage>3330</lpage><pub-id pub-id-type="pmid">20200276</pub-id></mixed-citation></ref><ref id="r64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>H.</given-names></name><name><surname>Mizumo</surname><given-names>S.</given-names></name><name><surname>Horai</surname><given-names>R.</given-names></name><name><surname>Iwakura</surname><given-names>Y.</given-names></name><name><surname>Sugawara</surname><given-names>I.</given-names></name></person-group>. <year>2000</year>. <article-title>Protective role of interleukin-1 in mycobacterial infection in IL-1&#x003b1;/&#x003b2; double-knockout mice.</article-title>
<source>Lab. Invest.</source>
<volume>80</volume>: <fpage>759</fpage>&#x02013;<lpage>767</lpage><pub-id pub-id-type="pmid">10830786</pub-id></mixed-citation></ref><ref id="r65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Chow</surname><given-names>J. M.</given-names></name><name><surname>Gri</surname><given-names>G.</given-names></name><name><surname>Carra</surname><given-names>G.</given-names></name><name><surname>Gerosa</surname><given-names>F.</given-names></name><name><surname>Wolf</surname><given-names>S. F.</given-names></name><name><surname>Dzialo</surname><given-names>R.</given-names></name><name><surname>Trinchieri</surname><given-names>G.</given-names></name></person-group>. <year>1996</year>. <article-title>The interleukin 12 p40 gene promoter is primed by interferon &#x003b3; in monocytic cells.</article-title>
<source>J. Exp. Med.</source>
<volume>183</volume>: <fpage>147</fpage>&#x02013;<lpage>157</lpage><pub-id pub-id-type="pmid">8551218</pub-id></mixed-citation></ref><ref id="r66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molle</surname><given-names>C.</given-names></name><name><surname>Goldman</surname><given-names>M.</given-names></name><name><surname>Goriely</surname><given-names>S.</given-names></name></person-group>. <year>2010</year>. <article-title>Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process.</article-title>
<source>J. Immunol.</source>
<volume>184</volume>: <fpage>1784</fpage>&#x02013;<lpage>1792</lpage><pub-id pub-id-type="pmid">20083668</pub-id></mixed-citation></ref><ref id="r67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Ghilardi</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Baker</surname><given-names>T.</given-names></name><name><surname>Xie</surname><given-names>M. H.</given-names></name><name><surname>Gurney</surname><given-names>A.</given-names></name><name><surname>Grewal</surname><given-names>I. S.</given-names></name><name><surname>de Sauvage</surname><given-names>F. J.</given-names></name></person-group>. <year>2000</year>. <article-title>Development of Th1-type immune responses requires the type I cytokine receptor TCCR.</article-title>
<source>Nature</source>
<volume>407</volume>: <fpage>916</fpage>&#x02013;<lpage>920</lpage><pub-id pub-id-type="pmid">11057672</pub-id></mixed-citation></ref><ref id="r68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;lscher</surname><given-names>C.</given-names></name><name><surname>H&#x000f6;lscher</surname><given-names>A.</given-names></name><name><surname>R&#x000fc;ckerl</surname><given-names>D.</given-names></name><name><surname>Yoshimoto</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>H.</given-names></name><name><surname>Mak</surname><given-names>T.</given-names></name><name><surname>Saris</surname><given-names>C.</given-names></name><name><surname>Ehlers</surname><given-names>S.</given-names></name></person-group>. <year>2005</year>. <article-title>The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis.</article-title>
<source>J. Immunol.</source>
<volume>174</volume>: <fpage>3534</fpage>&#x02013;<lpage>3544</lpage><pub-id pub-id-type="pmid">15749890</pub-id></mixed-citation></ref><ref id="r69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mascanfroni</surname><given-names>I. D.</given-names></name><name><surname>Yeste</surname><given-names>A.</given-names></name><name><surname>Vieira</surname><given-names>S. M.</given-names></name><name><surname>Burns</surname><given-names>E. J.</given-names></name><name><surname>Patel</surname><given-names>B.</given-names></name><name><surname>Sloma</surname><given-names>I.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Mayo</surname><given-names>L.</given-names></name><name><surname>Ben-Hamo</surname><given-names>R.</given-names></name><name><surname>Efroni</surname><given-names>S.</given-names></name><etal/></person-group>. <year>2013</year>. <article-title>IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.</article-title>
<source>Nat. Immunol.</source>
<volume>14</volume>: <fpage>1054</fpage>&#x02013;<lpage>1063</lpage><pub-id pub-id-type="pmid">23995234</pub-id></mixed-citation></ref><ref id="r70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrnes</surname><given-names>A. A.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Cuomo</surname><given-names>P.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Wahl</surname><given-names>L.</given-names></name><name><surname>Wolf</surname><given-names>S. F.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Trinchieri</surname><given-names>G.</given-names></name><name><surname>Karp</surname><given-names>C. L.</given-names></name></person-group>. <year>2001</year>. <article-title>Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity.</article-title>
<source>Eur. J. Immunol.</source>
<volume>31</volume>: <fpage>2026</fpage>&#x02013;<lpage>2034</lpage><pub-id pub-id-type="pmid">11449355</pub-id></mixed-citation></ref><ref id="r71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousens</surname><given-names>L. P.</given-names></name><name><surname>Orange</surname><given-names>J. S.</given-names></name><name><surname>Su</surname><given-names>H. C.</given-names></name><name><surname>Biron</surname><given-names>C. A.</given-names></name></person-group>. <year>1997</year>. <article-title>Interferon-&#x003b1;/&#x003b2; inhibition of interleukin 12 and interferon-&#x003b3; production in vitro and endogenously during viral infection.</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<volume>94</volume>: <fpage>634</fpage>&#x02013;<lpage>639</lpage><pub-id pub-id-type="pmid">9012836</pub-id></mixed-citation></ref><ref id="r72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousens</surname><given-names>L. P.</given-names></name><name><surname>Peterson</surname><given-names>R.</given-names></name><name><surname>Hsu</surname><given-names>S.</given-names></name><name><surname>Dorner</surname><given-names>A.</given-names></name><name><surname>Altman</surname><given-names>J. D.</given-names></name><name><surname>Ahmed</surname><given-names>R.</given-names></name><name><surname>Biron</surname><given-names>C. A.</given-names></name></person-group>. <year>1999</year>. <article-title>Two roads diverged: interferon &#x003b1;/&#x003b2;- and interleukin 12-mediated pathways in promoting T cell interferon &#x003b3; responses during viral infection.</article-title>
<source>J. Exp. Med.</source>
<volume>189</volume>: <fpage>1315</fpage>&#x02013;<lpage>1328</lpage><pub-id pub-id-type="pmid">10209048</pub-id></mixed-citation></ref><ref id="r73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalod</surname><given-names>M.</given-names></name><name><surname>Hamilton</surname><given-names>T.</given-names></name><name><surname>Salomon</surname><given-names>R.</given-names></name><name><surname>Salazar-Mather</surname><given-names>T. P.</given-names></name><name><surname>Henry</surname><given-names>S. C.</given-names></name><name><surname>Hamilton</surname><given-names>J. D.</given-names></name><name><surname>Biron</surname><given-names>C. A.</given-names></name></person-group>. <year>2003</year>. <article-title>Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon &#x003b1;/&#x003b2;.</article-title>
<source>J. Exp. Med.</source>
<volume>197</volume>: <fpage>885</fpage>&#x02013;<lpage>898</lpage><pub-id pub-id-type="pmid">12682109</pub-id></mixed-citation></ref><ref id="r74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>G.</given-names></name><name><surname>Humbert</surname><given-names>M.</given-names></name><name><surname>Deauvieau</surname><given-names>F.</given-names></name><name><surname>Scuiller</surname><given-names>M.</given-names></name><name><surname>Hiscott</surname><given-names>J.</given-names></name><name><surname>Bates</surname><given-names>E. E.</given-names></name><name><surname>Trinchieri</surname><given-names>G.</given-names></name><name><surname>Caux</surname><given-names>C.</given-names></name><name><surname>Garrone</surname><given-names>P.</given-names></name></person-group>. <year>2005</year>. <article-title>A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.</article-title>
<source>J. Exp. Med.</source>
<volume>201</volume>: <fpage>1435</fpage>&#x02013;<lpage>1446</lpage><pub-id pub-id-type="pmid">15851485</pub-id></mixed-citation></ref><ref id="r75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>R.</given-names></name><name><surname>Murray</surname><given-names>H. W.</given-names></name><name><surname>Nathan</surname><given-names>C. F.</given-names></name></person-group>. <year>1988</year>. <article-title>Agonist and antagonist effects of interferon &#x003b1; and &#x003b2; on activation of human macrophages. Two classes of interferon &#x003b3; receptors and blockade of the high-affinity sites by interferon &#x003b1; or &#x003b2;.</article-title>
<source>J. Exp. Med.</source>
<volume>167</volume>: <fpage>1171</fpage>&#x02013;<lpage>1185</lpage><pub-id pub-id-type="pmid">2965208</pub-id></mixed-citation></ref><ref id="r76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deguchi</surname><given-names>M.</given-names></name><name><surname>Sakuta</surname><given-names>H.</given-names></name><name><surname>Uno</surname><given-names>K.</given-names></name><name><surname>Inaba</surname><given-names>K.</given-names></name><name><surname>Muramatsu</surname><given-names>S.</given-names></name></person-group>. <year>1995</year>. <article-title>Exogenous and endogenous type I interferons inhibit interferon-&#x003b3;-induced nitric oxide production and nitric oxide synthase expression in murine peritoneal macrophages.</article-title>
<source>J. Interferon Cytokine Res.</source>
<volume>15</volume>: <fpage>977</fpage>&#x02013;<lpage>984</lpage><pub-id pub-id-type="pmid">8590310</pub-id></mixed-citation></ref></